Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

Drug Delivery Systems: Different Types

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Electrospun bioactive polymer biomaterials enriched with collagen and platelet-rich plasma as a platform for <i>in vitro</i> chondrogenic differentiation of human mesenchymal stem cells.

Frontiers in bioengineering and biotechnology·2026

Same author

Gene expression, purification, and functional characterization of recombinant conotoxin μ-TIIIA and TIIIAlaMut in <i>Escherichia coli</i> with clinical evaluation of antiwrinkle efficacy.

Biotechnologia·2026

Same author

Modeling and experimental verification of polycaprolactone nanoparticle precipitation.

Scientific reports·2026

Same author

Electrospun bioactive polymer biomaterials enriched with collagen and platelet-rich plasma as a platform for <i>in vitro</i> chondrogenic differentiation of human mesenchymal stem cells.

Frontiers in bioengineering and biotechnology·2025

Same author

Biodistribution of Polyaldehydedextran Nanoparticle-Encapsulated Epirubicin in Ovarian Tumor-Bearing Mice via Optical Imaging.

International journal of molecular sciences·2025

Same author

Antimicrobial Macrocycles - Synthesis, Characterization, and Activity Comparison with Their Linear Polycationic Analogues.

Biomacromolecules·2024

Search research articles

Related Experiment Video

Updated: May 29, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

Advanced trans-epithelial drug delivery devices.

Tomasz Ciach¹, Aleksandra Moscicka-Studzinska

¹Warsaw University of Technology, ul. Warynskiego 1, 00-645 Warsaw, Poland. t.ciach@ichip.pw.edu.pl

Current Pharmaceutical Biotechnology

|September 10, 2011

Summary

Advanced drug delivery devices for transdermal and transmucosal routes are reviewed. These intelligent systems aim to monitor metabolism and deliver precise drug doses for improved bodily regulation.

More Related Videos

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 29, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring

Published on: September 27, 2024

Area of Science:

Biomedical Engineering
Drug Delivery Systems
Medical Devices

Background:

Current drug delivery systems face limitations in real-time metabolic response.
Implantable electronic drug delivery devices present developmental and legal challenges.
Transdermal and transmucosal routes offer viable alternatives for advanced drug delivery.

Purpose of the Study:

To review advanced drug delivery devices focusing on transdermal and transmucosal applications.
To explore the operational principles and construction of intelligent drug delivery systems.
To discuss methods for integrating feedback loops for metabolic monitoring and regulation.

Main Methods:

Review of existing literature on advanced drug delivery devices.
Analysis of operational principles and design considerations for transdermal/transmucosal systems.
Exploration of body fluid sampling techniques for closed-loop drug delivery.

Main Results:

Description of intelligent drug delivery systems operating via skin or mucosa.
Identification of methods for sampling body fluids to enable feedback control.
Discussion of the potential for these devices to monitor metabolism and regulate body functions.

Conclusions:

Advanced drug delivery devices are evolving towards intelligent systems for transdermal and transmucosal administration.
Feedback mechanisms are crucial for real-time metabolic monitoring and precise drug dosing.
Future devices promise automated regulation of bodily functions through sophisticated drug and hormone delivery.